Home > News>Significant News

Minister Wang Wentao met with David A. Ricks, chair and CEO of Eli Lilly and Company

On March 21, Commerce Minister Wang Wentao met with David A. Ricks, chair and CEO of Eli Lilly and Company, and discussed with him China-US relations and Lilly’s development in China.

Wang Wentao said that health is an important measure of people’s well-being. He stressed China’s commitment to build a Healthy China that puts people first. He said that as the second largest pharmaceutical market in the world, China will create a broad space for Lilly and other multinational pharmaceutical companies. He hoped that Lilly, with years of operation in China, will continue to invest in China and provide more high-quality pharmaceutical products and services to benefit the Chinese people and contribute to the development of the pharmaceutical industry. He reaffirmed China’s commitment to high-quality development through high-standard opening-up, and fostering a market-oriented, law-based and world-class business environment, and sound service provision for foreign-funded enterprises.

David A. Ricks gave a briefing on Lilly’s global business and underlined its commitment to the Chinese market. He expressed willingness to increase investment in China and reinforce R&D cooperation to provide better products and services for the Chinese market.

(All information published on this website is authentic in Chinese. English is provided for reference only.)